search
Back to results

Chorioamnionitis: Observation of at Risk Infants vs Standard Care (CHORIS-RCT)

Primary Purpose

Chorioamnionitis, Early Onset Neonatal Sepsis, Sepsis of the Newborn

Status
Withdrawn
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Clinical observation
Standard management
Sponsored by
IRCCS Burlo Garofolo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Chorioamnionitis focused on measuring Chorioamnionitis, Early onset neonatal sepsis, Antibiotics, Clinical observation

Eligibility Criteria

10 Minutes - 6 Hours (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

- asymptomatic newborns born at term (>= 37 weeks of gestational age)

Exclusion Criteria:

  • preterm newborns (< 37 weeks gestational age)
  • sepsis-related signs of symptoms at birth
  • intensive care admittance

Sites / Locations

  • Institute for Maternal and Child Health IRCCS Burlo Garofolo

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Clinical observation

Standard management

Arm Description

Asymptomatic newborns born at term to mothers with suspected chorioamnionitis. They will receive a limited evaluation (blood culture, complete blood count), and a clinical observation. Antibiotics will be started only if sepsis-related signs or symptoms are present.

Asymptomatic newborns born at term to mothers with suspected chorioamnionitis. The will receive a limited evaluation (blood culture, complete blood count), a clinical observation and antibiotics at birth.

Outcomes

Primary Outcome Measures

Sepsis-related signs and symptoms
Presence of pale/cyanotic/mottled skin, respiratory rate higher than 60 breaths/minute or respiratory distress

Secondary Outcome Measures

Mortality
Neonatal intensive care unit admittance
Days of antibiotics
Days of hospitalization

Full Information

First Posted
August 29, 2016
Last Updated
July 10, 2019
Sponsor
IRCCS Burlo Garofolo
search

1. Study Identification

Unique Protocol Identification Number
NCT02886910
Brief Title
Chorioamnionitis: Observation of at Risk Infants vs Standard Care
Acronym
CHORIS-RCT
Official Title
Chorioamnionitis: Observation of at Risk Infants vs Standard Care. Randomized Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
July 2019
Overall Recruitment Status
Withdrawn
Study Start Date
October 2016 (Actual)
Primary Completion Date
October 2019 (Anticipated)
Study Completion Date
November 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
IRCCS Burlo Garofolo

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study evaluates the non-inferiority of a protocol of limited evaluation (complete blood count, blood culture) and clinical observation by standardized physical examination versus the algorithm suggested in the CDC's 2010 guidelines (limited evaluation, clinical observation and antibiotic therapy) in the management of asymptomatic infants born at term to mothers with suspected chorioamnionitis. The primary outcome of the study is the difference in the prevalence of sepsis-related symptoms between the two groups.
Detailed Description
Chorioamnionitis complicates 1-3% of pregnancies at term. The current international guidelines of the Center for Disease Control (CDC 2010) recommend that all asymptomatic newborns born to mothers with suspected chorioamnionitis undergo limited evaluation (i.e. blood culture at birth and complete blood count) and antibiotic therapy until the blood culture result is available. However, the prevalence of positive blood cultures in infants born to mothers with suspected chorioamnionitis is low, approximately 1%, including also infants requiring intensive care. This prevalence is even lower in asymptomatic infants. Moreover, the efficacy of antibiotic prophylaxis in preventing early sepsis, death or long-term sequelae in asymptomatic infants born to mothers with suspected chorioamnionitis has not been demonstrated. Early antibiotic use has been related to obesity and to the modification of microbiota. Limiting antibiotic use may prevent the emergence of antibiotic-resistant bacteria. Clinical observation is a reliable method to recognize infants with sepsis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chorioamnionitis, Early Onset Neonatal Sepsis, Sepsis of the Newborn
Keywords
Chorioamnionitis, Early onset neonatal sepsis, Antibiotics, Clinical observation

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Clinical observation
Arm Type
Experimental
Arm Description
Asymptomatic newborns born at term to mothers with suspected chorioamnionitis. They will receive a limited evaluation (blood culture, complete blood count), and a clinical observation. Antibiotics will be started only if sepsis-related signs or symptoms are present.
Arm Title
Standard management
Arm Type
Active Comparator
Arm Description
Asymptomatic newborns born at term to mothers with suspected chorioamnionitis. The will receive a limited evaluation (blood culture, complete blood count), a clinical observation and antibiotics at birth.
Intervention Type
Other
Intervention Name(s)
Clinical observation
Intervention Description
Antibiotics will be started only if sepsis-related signs or symptoms are present.Clinical observation consists in a standardized physical examination protocol according to which newborns are observed by the nurses at 1, 2, 4, 8, 12, 16, 20, 24 hours of life and then every 6 hours up to 48 hours of life. The following signs and symptoms are checked: skin colour (pink/pale/cyanotic/mottled), respiratory rate (lower or higher than 60 breaths/minute) and presence or absence of respiratory distress.
Intervention Type
Other
Intervention Name(s)
Standard management
Intervention Description
Antibiotics will be started at birth. Clinical observation will be carried out with the same timing and protocol
Primary Outcome Measure Information:
Title
Sepsis-related signs and symptoms
Description
Presence of pale/cyanotic/mottled skin, respiratory rate higher than 60 breaths/minute or respiratory distress
Time Frame
48 hours of life
Secondary Outcome Measure Information:
Title
Mortality
Time Frame
21 days
Title
Neonatal intensive care unit admittance
Time Frame
21 days
Title
Days of antibiotics
Time Frame
21 days
Title
Days of hospitalization
Time Frame
21 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
10 Minutes
Maximum Age & Unit of Time
6 Hours
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: - asymptomatic newborns born at term (>= 37 weeks of gestational age) Exclusion Criteria: preterm newborns (< 37 weeks gestational age) sepsis-related signs of symptoms at birth intensive care admittance
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sergio Demarini, MD
Organizational Affiliation
Institute for maternal and child health - IRCCS "Burlo Garofolo", Trieste, Italy
Official's Role
Study Director
Facility Information:
Facility Name
Institute for Maternal and Child Health IRCCS Burlo Garofolo
City
Trieste
State/Province
Friuli Venezia Giulia
ZIP/Postal Code
34137
Country
Italy

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Chorioamnionitis: Observation of at Risk Infants vs Standard Care

We'll reach out to this number within 24 hrs